Yipinhong Pharmaceutical Co Ltd Class A Tangible Net Worth Ratio
Yipinhong Pharmaceutical Co Ltd Class A tangible net worth ratio. Yipinhong Pharmaceutical Co Ltd Class A (300723) has a Tangible Net Worth Ratio of 77.2% as of June 2026. This metric is calculated by deducting intangible assets (CN¥428.91 Million) from net assets (CN¥1.88 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Yipinhong Pharmaceutical Co Ltd Class A (300723) net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Yipinhong Pharmaceutical Co Ltd Class A (2013–2025)
Tangible net worth ratio of Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2025. This chart shows how Yipinhong Pharmaceutical Co Ltd Class A's Tangible Net Worth Ratio has changed across 13 annual periods from 2013 to 2025. As of June 2026, the ratio stands at 77.2%, reflecting net assets of CN¥1.88 Billion with intangible assets of CN¥428.91 Million CNY. Check how strategically is Yipinhong Pharmaceutical Co Ltd Class A's equity deployed to assess the company's strategic physical and investment asset allocation.
Yipinhong Pharmaceutical Co Ltd Class A Tangible Net Worth Ratio by Year (2013–2025)
Yipinhong Pharmaceutical Co Ltd Class A tangible net worth ratio by year from 2013 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2025, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 300723 stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 68.2% | CN¥1.41 Billion | CN¥447.63 Million | CN¥4.04 Billion | ▼ -9.0 pp |
| 2024 | 77.2% | CN¥1.94 Billion | CN¥441.17 Million | CN¥4.40 Billion | ▼ -5.6 pp |
| 2023 | 82.8% | CN¥2.60 Billion | CN¥446.79 Million | CN¥4.41 Billion | ▲ +4.1 pp |
| 2022 | 78.7% | CN¥2.17 Billion | CN¥460.97 Million | CN¥4.10 Billion | ▲ +1.5 pp |
| 2021 | 77.2% | CN¥2.02 Billion | CN¥460.42 Million | CN¥3.70 Billion | ▼ -2.9 pp |
| 2020 | 80.0% | CN¥1.50 Billion | CN¥298.34 Million | CN¥2.15 Billion | ▲ +3.4 pp |
| 2019 | 76.7% | CN¥1.34 Billion | CN¥312.91 Million | CN¥1.79 Billion | ▲ +3.5 pp |
| 2018 | 73.1% | CN¥1.30 Billion | CN¥349.33 Million | CN¥1.78 Billion | ▼ -12.5 pp |
| 2017 | 85.6% | CN¥1.11 Billion | CN¥159.69 Million | CN¥1.48 Billion | ▲ +36.7 pp |
| 2016 | 48.9% | CN¥336.50 Million | CN¥171.91 Million | CN¥752.32 Million | ▲ +31.3 pp |
| 2015 | 17.7% | CN¥200.66 Million | CN¥165.23 Million | CN¥630.56 Million | ▲ +39.2 pp |
| 2014 | -21.6% | CN¥127.52 Million | CN¥155.01 Million | CN¥733.80 Million | ▼ -72.5 pp |
| 2013 | 51.0% | CN¥185.61 Million | CN¥90.99 Million | CN¥411.27 Million | — |